Severity
Low
FDA Drug recall · Reported August 23, 2017
Crystallization with subpotent out of specification assay results for chlorhexidine.
Akorn Inc recalled Halyard 24-Hour Oral Care Kit q4, contains 2x15 mL Unit Dose Cups 0.12% Chlorhexidine Glu… - a low-severity action.
Halyard 24-Hour Oral Care Kit q4, contains 2x15 mL Unit Dose Cups 0.12% Chlorhexidine Glu… was recalled by Akorn Inc in August 23, 2017. Reason: Crystallization with subpotent out of specification assay results for chlorhexidine.. Check the official notice for the remedy. Verify recall #D-1090-2017 with the FDA Drug before acting.
The recall
Akorn Inc issued this low-severity FDA Drug recall-Crystallization with subpotent out of specification assay results for chlorhexidine..
Sourced from official FDA Drug enforcement records. Verify recall #D-1090-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1090-2017) was formally reported on August 23, 2017, with the manufacturer initiating the action on July 12, 2017. It is classified under Low severity (Class III), with a current status of Terminated. Akorn Inc is listed as the recalling firm, operating out of Lake Forest, IL. Federal records list the affected scope as 101,952 15 mL unit dose cups.
The documented reason for this recall is: Crystallization with subpotent out of specification assay results for chlorhexidine. Distribution data in the federal record shows the product reached: Nationwide in the USA. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
101,952 15 mL unit dose cups
Related Recalls
6
5 from same agency
Halyard 24-Hour Oral Care Kit q4, contains 2x15 mL Unit Dose Cups 0.12% Chlorhexidine Gluconate Oral Rinse. Manufactured by Halyard Health Inc., 5405 Windward Parkway, Alpharetta, GA 30004. Distributed by Halyard Sales, LLC Alpharetta, GA 30004. REF # 97014
Crystallization with subpotent out of specification assay results for chlorhexidine.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-1090-2017 |
| Date reported | August 23, 2017 |
| Date initiated | July 12, 2017 |
| Recalling firm | Akorn Inc |
| Firm location | Lake Forest, IL |
| Affected scope | 101,952 15 mL unit dose cups |
| Distribution | Nationwide in the USA |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported August 23, 2017. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.